Aurinia Pharmaceuticals Inc.
AUPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600620
In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Aurinia Pharmaceuticals Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 191
- −4 vs. Q3 2023
- Shares held
- 54.0M
- +4.26M (+8.6%) vs. Q3 2023
- Total value
- $485.4M
- +$98.9M (+25.6%) vs. Q3 2023
- New holders
- 22
- 59 more added
- Sold out
- 26
- 64 more reduced
3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AUPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 282 | $1.34B |
| Q1 2026 | 260 | $1.10B |
| Q4 2025 | 256 | $1.15B |
| Q3 2025 | 242 | $729.8M |
| Q2 2025 | 219 | $497.1M |
| Q1 2025 | 214 | $504.1M |
| Q4 2024 | 200 | $525.4M |
| Q3 2024 | 183 | $428.9M |
| Q2 2024 | 171 | $319.9M |
| Q1 2024 | 178 | $280.8M |
| Q4 2023 | 191 | $485.4M |
| Q3 2023 | 198 | $395.2M |
| Q2 2023 | 200 | $487.5M |
| Q1 2023 | 186 | $553.5M |
| Q4 2022 | 192 | $223.1M |
| Q3 2022 | 189 | $420.5M |
| Q2 2022 | 199 | $509.9M |
| Q1 2022 | 184 | $532.9M |
| Q4 2021 | 191 | $895.1M |
| Q3 2021 | 167 | $966.8M |
| Q2 2021 | 167 | $640.9M |
| Q1 2021 | 170 | $682.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Aurinia Pharmaceuticals Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Algert Global LLC | 0 | $0 | 0.00% | −52,939−100.0% | Sold out |
| Moran Wealth Management, LLC | 0 | $0 | 0.00% | −26,268−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −25,050−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −24,506−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −24,261−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −19,400−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −17,109−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −15,391−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −13,533−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −12,812−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −10,398−100.0% | Sold out |
| Cary Street Partner Investment Advisory LLC | 0 | $0 | 0.00% | −1,560−100.0% | Sold out |
| Trust Co of Vermont | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −374−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −108−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Steward Financial Group LLC | – | – | – | – | Not filed |